Loading clinical trials...
Loading clinical trials...
Study aims to compare the influence of intravenous lidocaine and peridural ropivacaine on postoperative long and short term outcome in patients with pancreatic cancer undergoing surgery. As short term endpoints: postoperative complications and resumption of bowel function. Long term endpoints include: 1 and 3 year recurrence and mortality.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Regional Institute of Gastroenterology and Hepatology "Prof. Dr. O. Fodor"
Cluj-Napoca, Romania
Start Date
July 1, 2020
Primary Completion Date
December 31, 2021
Completion Date
December 31, 2024
Last Updated
June 26, 2020
100
ESTIMATED participants
Intravenous lidocaine
DRUG
Epidural ropivacaine
DRUG
Lead Sponsor
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor
NCT04550494
NCT05053971
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions